1. Home
  2. NUVL vs SUN Comparison

NUVL vs SUN Comparison

Compare NUVL & SUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$104.39

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Logo Sunoco LP

SUN

Sunoco LP

HOLD

Current Price

$53.57

Market Cap

7.1B

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
NUVL
SUN
Founded
2017
1886
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Integrated oil Companies
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
7.1B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
NUVL
SUN
Price
$104.39
$53.57
Analyst Decision
Strong Buy
Buy
Analyst Count
14
4
Target Price
$134.29
$63.75
AVG Volume (30 Days)
828.0K
503.7K
Earning Date
10-30-2025
11-05-2025
Dividend Yield
N/A
6.84%
EPS Growth
N/A
N/A
EPS
N/A
2.93
Revenue
N/A
$21,870,000,000.00
Revenue This Year
N/A
$2.83
Revenue Next Year
N/A
$10.99
P/E Ratio
N/A
$18.33
Revenue Growth
N/A
N/A
52 Week Low
$55.54
$47.98
52 Week High
$112.88
$59.88

Technical Indicators

Market Signals
Indicator
NUVL
SUN
Relative Strength Index (RSI) 51.87 48.17
Support Level $103.52 $52.76
Resistance Level $107.99 $54.43
Average True Range (ATR) 3.18 1.00
MACD -0.93 -0.24
Stochastic Oscillator 10.43 22.28

Price Performance

Historical Comparison
NUVL
SUN

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of the Company's operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

About SUN Sunoco LP

Sunoco LP is engaged in the distribution of motor fuels to independent dealers, distributors, and other commercial customers as well as the distribution of motor fuels to end-use customers at retail sites operated by commission agents. It is a growth-oriented master limited partnership (MLP) that operates as a wholesale and retail fuel distributor in the United States. The firm operates through the Fuel Distribution; Pipeline Systems; and Terminals segments. It generates the majority of its revenue from the Fuel Distribution segment. It distributes motor fuel to convenience stores, dealers, and commercial customers in various states. The operating convenience stores are under the APlus, Stripes, Aloha Island Mart, and Tigermarket brands.

Share on Social Networks: